Pfizer's payout looks like a safe harbor in a rough market, but the patent clock is ticking and the balance sheet leaves ...

Pfizer shareholders are collecting a 6% yield while the stock bleeds value, and the CEO just made a bold promise about ...

Follow this author to personalize your feed and get instant alerts. WHY FOLLOW? Custom Feed: See the stories that matter most to you. Smart Alerts: Get notified about major news as it happens. Update ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Watching the trades of company chief executive officers is a fascinating sport. It also can be profitable. Here are some ...

Pfizer is gearing up for a consumer-driven market for obesity drugs that could match the rapid growth it experienced after introducing erectile dysfunction drug Viagra more than 20 years ago, Chief ...

Albert Bourla, Pfizer's chief executiveFabrice Coffrini/AFP/Getty Images Pfizer Chief Executive Albert Bourla is battling impending expirations for some blockbuster-drug patents and the precipitous ...

Pfizer CEO Albert Bourla on Making Medicine in the U.S., Vaccines After COVID, and How He Gets Along With RFK Jr. Qualcomm ...